Exenatide in adolescent patients with type 2 diabetes: Pharmacokinetics, pharmacodynamics, safety, and

被引：0
|
作者：
Malloy, Jaret
Guan, Xuesong
Kothare, Prajakti.
Capparelli, Edmund
Fineman, Mark
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus
    Kolterman, OG
    Kim, DD
    Shen, L
    Ruggles, JA
    Nielsen, LL
    Fineman, MS
    Baron, AD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (02) : 173 - 181
  • [2] Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus
    Kothare, Prajakti A.
    Linnebjerg, Helle
    Isaka, Yoshitaka
    Uenaka, Kazunori
    Yamamura, Ayuko
    Yeo, Kwee Poo
    de la Pena, Amparo
    Teng, Choo Hua
    Mace, Kenneth
    Fineman, Mark
    Shigeta, Hirofumi
    Sakata, Yukikuni
    Irie, Shin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (12): : 1389 - 1399
  • [3] Intranasal administration of exenatide in patients with type 2 diabetes: pharmacokinetics, pharmacodynamics, safety and tolerability
    Blase, E.
    Deng, W.
    Walsh, B.
    Fineman, M.
    Rhodes, C.
    DIABETOLOGIA, 2008, 51 : S346 - S346
  • [4] Intranasal administration of exenatide in patients with type 2 diabetes: Pharmacokinetics, pharmacodynamics, safety, and tolerability
    Blase, Erich
    Deng, Wei
    Walsh, Brandon
    Fine-Man, Mark
    Rhodes, Christopher
    DIABETES, 2008, 57 : A58 - A58
  • [5] Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes
    Linnebjerg, H.
    Kothare, P. A.
    Seger, M.
    Wolka, A. M.
    Mitchell, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) : 99 - 108
  • [6] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients with Type 2 Diabetes
    Iwamoto, Kazuya
    Nasu, Risa
    Yamamura, Ayuko
    Kothare, Prajakti A.
    Mace, Kenneth
    Wolka, Anne M.
    Linnebjerg, Helle
    ENDOCRINE JOURNAL, 2009, 56 (08) : 951 - 962
  • [7] Multiple dose safety, tolerability, and Pharmacokinetics/Pharmacodynamics of exenatide in Japanese patients with type 2 diabetes
    Kothare, Prajakti
    Linnebjerg, Helle
    Isaka, Yoshitaka
    Uenaka, Kazunori
    Yamamura, Ayuko
    Shigeta, Hirofumi
    Yeo, Kwee Poo
    Teng, Choo Hua
    De La Apena, Amparo
    Mace, Kenneth
    Fineman, Mark
    Sakata, Yukikuni
    Irie, Shin
    DIABETES, 2006, 55 : A461 - A461
  • [8] Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients with Type 2 Diabetes
    Iwamoto, Kazuya
    Nasu, Risa
    Yamamura, Ayuko
    Kothare, Prajakti A.
    Wolka, Anne M.
    Linnebjerg, Helle
    DIABETES, 2009, 58 : A163 - A163
  • [9] Pharmacokinetics, pharmacodynamics, safety and tolerability of single dose exenatide in very elderly patients (≥75 years) with type 2 diabetes
    Linnebjerg, H.
    Kothare, P. A.
    Seger, M.
    Mitchell, M.
    DIABETOLOGIA, 2009, 52 : S308 - S308
  • [10] Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
    Hiroaki Iijima
    Takayuki Kifuji
    Nobuko Maruyama
    Nobuya Inagaki
    Advances in Therapy, 2015, 32 : 768 - 782
12345